Open

Coming up

Don't miss

Replay


LATEST SHOWS

THE INTERVIEW

Patrick Chauvel, French war photographer

Read more

BUSINESS DAILY

Scottish fishing industry divided over independence

Read more

IN THE PAPERS

Alex Salmond's "emotional eve-of poll plea to Scots to seize their historic opportunity"

Read more

IN THE PAPERS

Valls is starting to act like Hollande

Read more

WEB NEWS

Wikileaks releases "weaponized malware" customer list

Read more

DEBATE

Hollande on his own? Socialist backbenchers abstain on confidence vote

Read more

DEBATE

Hollande on his own? Socialist backbenchers abstain on confidence vote (part 2)

Read more

MEDIAWATCH

Ukraine politician thrown on rubbish heap

Read more

THE INTERVIEW

'Iraq wants role for Iran in anti-IS coalition', says foreign minister

Read more

Sanofi-Aventis withdraws anti-obesity drug from European shelves

Text by AFP

Latest update : 2008-10-24

EU authorities have suspended sales of pharmaceutical giant Sanofi-Aventis' anti-obesity drug Acomplia across the continent, due to an abnormal risk of psychiatric problems.

EU authorities suspended sales of pharmaceutical giant Sanofi-Aventis' anti-obesity drug Acomplia across the continent Thursday, the firm announced, adding that it had not ruled out a worldwide halt.

"Sales have been halted in all the pharmacies in the 18 countries of the European Union where it is distributed," a company spokesman told AFP.

Sanofi-Aventis said the European Medicines Agency (EMEA) had warned that patients taking the drug ran almost double the normal risk of psychiatric problems.

"The risks of taking Acomplia are now greater than the benefits that the drug can bring the patient according to its current guidelines," the company said, citing the EMEA.

Europe has allowed sales of Acomplia since 2006, but it has not been authorised in the United States where authorities believe it encourages suicidal thoughts, even in patients with no history of depression.

The company said it had not ruled out withdrawing the drug in the 14 non-EU countries where it is sold. It said users of the drug should consult a doctor or pharmacist.
 

Date created : 2008-10-24

COMMENT(S)